How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

935 results for

Medication Causes of Dyspepsia

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation

with suspected OIC involves first taking a careful history to evaluate defecation patterns; dietary patterns; stool consistency; symptoms of dyssynergic defecation (eg, a sensation of incomplete evacuation); or alarm symptoms, such as blood in stool or accompanying weight loss. A medical history should also be taken to assess comorbid illnesses and regular medication use. Other potential causes or contributors to constipation should be explored and excluded, such as pelvic outlet dysfunction, mechanical (...) ., Dorn, S.D. et al. American Gastroenterological Association medical position statement on constipation. Gastroenterology . 2013 ; 144 : 211–217 | | | | | Once a diagnosis of OIC has been confirmed and other potential causes of constipation are excluded, the recommendations here can help guide appropriate evidence-based management. This guideline focuses on the medical management of OIC. Therefore, it does not address the role of psychological therapy, alternative medicine approaches, surgery

2019 American Gastroenterological Association Institute

22. Dyspepsia: When and How to Test for Helicobacter pylori Infection (PubMed)

Dyspepsia: When and How to Test for Helicobacter pylori Infection Dyspepsia is defined as symptoms related to the upper gastrointestinal tract. Approximately 25% of western populations complain of dyspeptic symptoms each year. 70% of them do not have an organic cause and symptoms are related to the so-called functional dyspepsia, characterized by epigastric pain, early satiety, and/or fullness during or after a meal occurring at least weekly and for at least 6 months according to ROME III (...) criteria. In order to avoid invasive procedures and adverse effects, to minimize costs, to speed up diagnosis, and to provide the most appropriate treatments, primary care physicians need to recognize functional dyspepsia. Because symptoms do not reliably discriminate between organic and functional forms of the disease, anamnesis, family history of peptic ulcer and/or of gastric cancer, medication history, especially for nonsteroidal anti-inflammatory drugs, age, and physical examination could help

Full Text available with Trip Pro

2016 Gastroenterology research and practice

23. Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia.

in their symptoms on the diet. This improvement could be explained by reduction in duodenal and gastric distention with the low FODMAP diet or a change in the duodenal flora. To date, there have been no randomized trials evaluating dietary modification in FD. The purpose of this study is to evaluate the efficacy of the low FODMAP diet in functional dyspepsia. The investigator's hypothesis is that the addition of the FODMAP diet to standard medical treatment will result in improved symptom control in patients (...) (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Men and women 18 years and older Diagnosis of FD with either PDS or EPS as measured by Rome III Criteria Patients describing inadequate relief of dyspepsia symptoms Endoscopy performed in the last 3 years and negative for an organic cause for dyspeptic symptoms H pylori negative by non-invasive testing or biopsy. Patients with a history of successfully eradicated H pylori will be included

2016 Clinical Trials

24. Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia

. Have a Body Mass Index (BMI) between 18.5-30. Absence of significant structural/organic abnormalities on abdominal ultrasound and upper gastrointestinal endoscopy performed within the last 3 months prior to baseline to exclude a structural cause for the symptoms. Negative Helicobacter Pylori urea breath test. Presence of at least three out of the assessed ten symptoms judged to be at least of moderate or severe intensity, assessed after withdrawal of any medication potentially affecting (...) Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding

2016 Clinical Trials

25. Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia.

of medical service , also reduce health care cost and unequally medical information. Anxiety and depression are two common reactions when it comes to negative emotional states, which related to a body and caused a vicious cycle of disease. Some patients suffer from functional dyspepsia symptoms were diagnosed with anxiety or depression symptoms often ignore body care due to lack of health literacy. The purpose of this study is to investigate the distribution of functional dyspepsia patients with health (...) ). Please remove one or more studies before adding more. Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02737683 Recruitment Status : Unknown Verified March 2017 by Ming-Shun Wu, Taipei Medical

2016 Clinical Trials

26. Dyspepsia

, Functional Dyspepsia , Gastritis , Duodenitis , Acid-Related Dyspepsia From Related Chapters II. Definition Chronic or recurrent III. Epidemiology Dyspepsia overall : 40% of adults in U.S IV. Causes See See V. Pathophysiology Unclear etiology, however may be related to altered gastric motility often found in patients with Dyspepsia, but causality is not clear VI. Symptoms Epigastric burning, pain or discomfort Early satiety Associated symptoms (difficult to treat) and and Halitosis VII. Diagnosis: Rome (...) to higher doses Adjunctive medication options Metoclopramide (prokinetic agent) May offer benefit in Nonulcer Dyspepsia Risk of tardive diskinesia Ineffective Medications (avoid) Sucralfate offers no benefit in Nonulcer Dyspepsia Misoprostel offers no benefit in Nonulcer Dyspepsia XII. Approach: Step 4 - Consider Helicobacter Pylori testing Indications Lack of relief with empiric antisecretory therapy Undifferentiated Dyspepsia treatment does not benefit without ulcer However ulcer status unknown

2018 FP Notebook

27. Association of anxiety, depression, and psychological distress in people with and without functional dyspepsia (PubMed)

Association of anxiety, depression, and psychological distress in people with and without functional dyspepsia Current studies have indicated a high ratio of psychological problems in functional dyspepsia (FD) which causes disturbance in its management, so recognition these problems help the process of treatment.This was a cross-sectional study with a sample size of 4763 carried out in Isfahan University of Medical Sciences in 2011. Modified ROME III questionnaire was used to evaluate FD

Full Text available with Trip Pro

2016 Advanced biomedical research

28. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity

American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity ENDOCRINE PRACTICE Vol 22 (Suppl 3) July 2016 1 AACE/ACE Guidelines AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY W. Timothy Garvey, MD, FACE 1 ; Jeffrey I. Mechanick, MD, FACP , FACE, FACN, ECNU 2 (...) ; Elise M. Brett, MD, FACE, CNSC, ECNU 3 ; Alan J. Garber, MD, PhD, FACE 4 ; Daniel L. Hurley, MD, FACE 5 ; Ania M. Jastreboff, MD, PhD 6 ; Karl Nadolsky, DO 7 ; Rachel Pessah-Pollack, MD 8 ; Raymond Plodkowski, MD 9 ; and Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines* American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice are systematically devel- oped statements to assist health care professionals in medical decision-making for specific clinical

2016 American Association of Clinical Endocrinologists

29. Letermovir (Prevymis) - to prevent illness caused by cytomegalovirus (CMV) in adults having an allogeneic haematopoietic stem cell transplant

Letermovir (Prevymis) - to prevent illness caused by cytomegalovirus (CMV) in adults having an allogeneic haematopoietic stem cell transplant 30 Churchill Place ? Canary Wharf ? London E14 5EU ? United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact © European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged. 9 November 2017 EMA/CHMP/490007/2017 (...) . Discussion on clinical safety 114 2.6.2. Conclusions on the clinical safety 115 2.7. Risk Management Plan 115 2.8. Pharmacovigilance 116 2.9. New Active Substance 116 2.10. Product information 117 2.10.1. User consultation 117 2.10.2. Labelling exemptions 117 Assessment report EMA/CHMP/490007/2017 Page 3/124 2.10.3. Additional monitoring 117 3. Benefit-Risk Balance 118 3.1. Therapeutic Context 118 3.1.1. Disease or condition 118 3.1.2. Available therapies and unmet medical need 118 3.1.3. Main clinical

2018 European Medicines Agency - EPARs

30. Dyspepsia Causes

Dyspepsia Causes Dyspepsia Causes Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Dyspepsia Causes Dyspepsia Causes Aka: Dyspepsia (...) sampling from a Bing search on the term "Dyspepsia Causes." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Dyspepsia (C0013395) Definition (MEDLINEPLUS) Nearly everyone has had indigestion at one time. It's a feeling of discomfort or a burning feeling in your upper abdomen. You may have or belch and feel bloated. You may also feel nauseated, or even throw up. You might get indigestion from eating too much or too

2015 FP Notebook

31. Fibrositis of Rectus Abdominis Muscles causing Dyspepsia (PubMed)

Fibrositis of Rectus Abdominis Muscles causing Dyspepsia 20785552 2011 04 04 2011 04 04 0007-1447 2 4359 1944 Jul 22 British medical journal Br Med J Fibrositis of Rectus Abdominis Muscles causing Dyspepsia. 114 Harvey R S RS eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1944 7 22 0 0 1944 7 22 0 1 ppublish 20785552 PMC2285856

Full Text available with Trip Pro

1944 British medical journal

32. Gallstones and flatulent dyspepsia: cause or coincidence? (PubMed)

Gallstones and flatulent dyspepsia: cause or coincidence? 5138744 1972 04 06 2018 11 13 0032-5473 47 554 1971 Dec Postgraduate medical journal Postgrad Med J Gallstones and flatulent dyspepsia: cause or coincidence? 767-72 Johnson A G AG eng Journal Article England Postgrad Med J 0234135 0032-5473 0 Dietary Fats IM Cholecystography Cholelithiasis complications Dietary Fats Dyspepsia complications Female Flatulence complications Humans Male Middle Aged 1971 12 1 1971 12 1 0 1 1971 12 1 0 0

Full Text available with Trip Pro

1971 Postgraduate medical journal

33. A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease (PubMed)

A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease 20749184 2011 03 29 2011 03 29 0007-1447 1 956 1879 Apr 26 British medical journal Br Med J A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease. 622-3 Leared A A eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1879 4 26 0 0 1879 4 26 0 1 ppublish 20749184 PMC2240030

Full Text available with Trip Pro

1879 British medical journal

34. A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease (PubMed)

A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease 20749190 2011 03 29 2011 03 29 0007-1447 1 957 1879 May 03 British medical journal Br Med J A Neglected Proximate Cause of Dyspepsia, with a New Division of the Disease. 660-1 Leared A A eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1879 5 3 0 0 1879 5 3 0 1 ppublish 20749190 PMC2240286

Full Text available with Trip Pro

1879 British medical journal

35. Remarks ON THE CAUSES AND TREATMENT OF FUNCTIONAL DYSPEPSIA (PubMed)

Remarks ON THE CAUSES AND TREATMENT OF FUNCTIONAL DYSPEPSIA 20764965 2011 03 29 2011 03 29 0007-1447 1 2567 1910 Mar 12 British medical journal Br Med J Remarks ON THE CAUSES AND TREATMENT OF FUNCTIONAL DYSPEPSIA. 613-6 Drummond D D eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1910 3 12 0 0 1910 3 12 0 1 ppublish 20764965 PMC2330717

Full Text available with Trip Pro

1910 British medical journal

36. THE EXISTENCE OF LIVING CREATURES IN THE STOMACH AS A CAUSE OF CHRONIC DYSPEPSIA (PubMed)

THE EXISTENCE OF LIVING CREATURES IN THE STOMACH AS A CAUSE OF CHRONIC DYSPEPSIA 20764921 2011 03 29 2011 03 29 0007-1447 1 2563 1910 Feb 12 British medical journal Br Med J THE EXISTENCE OF LIVING CREATURES IN THE STOMACH AS A CAUSE OF CHRONIC DYSPEPSIA. 371-5 Fenwick W S WS eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1910 2 12 0 0 1910 2 12 0 1 ppublish 20764921 PMC2330345

Full Text available with Trip Pro

1910 British medical journal

37. A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02567578 Recruitment Status : Suspended (due to dose re-selection) First Posted : October 5, 2015 Last Update Posted : September 7

2015 Clinical Trials

38. Mosapride treatment for functional dyspepsia: a meta-analysis. (PubMed)

assessment outcomes are causes of heterogeneity. Further studies using common validated outcomes or questionnaires and high-quality RCTs will elucidate the real effect of this medication on FD.© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. (...) Mosapride treatment for functional dyspepsia: a meta-analysis. The aim of this study was to assess the therapeutic effect of mosapride in patients with functional dyspepsia (FD).Randomized controlled trials (RCTs) of mosapride for the treatment of FD performed between 2002 and 2013 were identified from databases. Symptom response rates were extracted and analyzed using risk ratios (RRs). A random effect model was applied based on Higgins I(2) tests. Publication bias was evaluated using a funnel

2015 Journal of gastroenterology and hepatology

39. Effects of Diet on Reflux and Dyspepsia

Effects of Diet on Reflux and Dyspepsia Effects of Diet on Reflux and Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effects of Diet on Reflux and Dyspepsia The safety and scientific validity (...) affecting 10-20% of the population on a regular basis. Reflux symptoms such as heartburn and regurgitation are caused by the return of acid or non-acid gastric contents into the esophagus. Dyspeptic symptoms are caused by abnormal gastric relaxation (impaired accommodation) or increased sensitivity of the stomach to distension during the meal. The effects of diet on gastrointestinal function are debated and the efficacy of dietary management for digestive symptoms has not been established

2015 Clinical Trials

40. Diagnosis and Treatment of Chronic Undiagnosed Dyspepsia in Adults

or belching and early satiety. Heartburn and regurgitation are symptoms most commonly associated with gastroesophageal reflux disease (GERD) but these symptoms can occur in dyspepsia together with the other listed upper GI symptoms. RECOMMENDATIONS ? Inquire about precipitating factors (see Table 1) and attempt to correct (see Algorithm). PRECIPITATING FACTORS ? NSAID/ASA use and other prescription medications (i.e., calcium channel blockers, bisphosphonates) ? Smoking and excessive alcohol use ? Dietary (...) are discriminatory. Many diseases can cause dyspepsia, including peptic ulcers (duodenal or gastric ulcers), GERD, cancer of the stomach and pancreas, and gallstones. However, many patients with dyspepsia will not have evidence of underlying organic disease – this is referred to as functional dyspepsia. 3 Clinicians Chronic Undiagnosed Dyspepsia in Adults | January 2009 Clinical Practice Guideline Page 3 of 8 Background can detect serious disease by identifying alarm features, testing selected patients for H

2009 Toward Optimized Practice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>